Navigation Links
OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock
Date:11/5/2009

FORT WORTH, Texas, Nov. 5 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (WNDM), announced today that it has entered into a Letter of Intent to purchase all healthcare-related assets of Virtual Health Technologies, Inc. (OTC Bulletin Board: VHGI). The deal provides for VHGI to be paid $1,000,000 in cash and debt, 4,000,000 shares of WNDM and a royalty agreement for revenues generated by WNDM on the Veriscrip technology being acquired from VHGI. WNDM closed at $2.00 per share on 11/4/09 and VHGI closed at $0.27 per share on 11/4/09.

"WNDM will be acquiring Medical Office Software, Inc. (MOS), Secure eHealth, LLC, and the Veriscrip technology from Virtual Health Technologies, Inc.," stated Scott Haire, CEO of WNDM. "These businesses fit well with WNDM's domestic plans to leverage its existing infrastructure to develop opportunities within the Healthcare marketplace, and focus on the U.S. Government healthcare technology Initiative. We are confident that this will add tremendously to our bottom line. WNDM will continue to target major pharmaceutical companies from both a wound care product perspective as well as a medical technology company, and focus on increasing revenues and maximizing shareholder value."

"WNDM will be able to significantly expand its product distribution throughout various medical facilities with the acquisition of an established client base of approximately 1,500 doctors throughout the US currently using our technology. In addition many of these physicians have ongoing relationships with nursing homes which necessitate a need for improved wound care technology. This acquisition translates into the potential for significant increased sales for WNDM's core wound care product line," stated Ken Barnes, President of Medical Office Software.

Debbie Jenkins, Board member of VHGI, states, "As we continue to work with e-health we realize VHGI's technology plus WNDM's core sales and development ne
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS
2. Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas
3. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
4. Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
5. Oncothyreon announces webcast of third quarter 2009 financial results conference call
6. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
7. Osteotech Announces Third Quarter 2009 Financial Results Release and Conference Call
8. Novavax Announces Release Date of 2009 Third Quarter Financial Results and Investor Conference Call
9. BMP Sunstone Announces November Investor Conference Participation
10. Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
11. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Health care employmen...emains the only one to show consistent growth duri...lty hospitals remain in trouble, and health system...cal personnel, instead of just administrators. , ...-- Health care employment continued growing in Oct...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEn...ublicDevelopmentAuthority(OPDA)wererecentlyawarded...alizationBoard(CERB)inaprivate/publicpartnershipto...ineryinLincolnCounty,WA. ,, "Thisinvestmentwill...dbringover70greenjobstoLincolnCounty,"saidBlueMarb...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24,2009/PRNewswire-FirstCal...ced todaythatthecompanyisscheduledtopresentattheP...r1,2009at11:30a.m.EasternTime(8:30a.m.PacificTime)...a,s President andChiefExecutiveOfficer,isscheduled...aldevelopmentanddiscoveryprograms. ,, Aliveaudi...
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Ce...entwillpresentatthe21stAnnualPiperJaffrayHealthCar...9,attheNewYorkPalaceHotel. ,, CTIwillpresentonT...hFloor).AliveaudiowebcastofCTI,spresentationwillbe...obeavailableforreplayafterwards. , ,PiperJaffrayH...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...nsional liquid chromatography (MDLC) • revers...MS/MS • DeCyder MS • differential analys...n conjunction with tandem mass spectrometry (MS/MS...racted from the pollen of the olive tree, Olea eu...oftware (DeCyder MS) was used to quantitate differ...
... DNA Genotek Inc., Ottawa, ON, Canada , ...l with TaqMan SNP Genotyping Assays. , SN...n E genes were reliably , detected., ...nucleotide polymorphisms (SNPs) are highly abundan...of every 1,000 bases in the human genome (ref. 1)....
... Ottawa, Ontario, Canada , , St...n add significant , costs to a project. O..., specimens to be stored for years at room..., , Introduction , L...to thousands of subjects, , are frequentl...
Other Biology Technology:Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 2Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 3Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 4Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 5Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 6Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 7Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 8Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS 9Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3DNA Stability with Oragene 2DNA Stability with Oragene 3
(Date:11/23/2009)... CHAMPAIGN, Ill. A new study provides "incontrov... of Toba on the island of Sumatra about 73,000 yea...0 miles from the epicenter, researchers report. ,...eters of ash into the atmosphere, leaving a crater...00 kilometers long and 35 kilometers wide. Ash fro...
(Date:11/23/2009)..., BIRMINGHAM, Ala. A new study by University of...t body-mass index (BMI) and co-existing medical co...ed survival observed among African-Americans compa...study is published online Nov. 23 in Cancer , a j...ding indicates that although BMI and co-morbidity ...
(Date:11/23/2009)...CORVALLIS, Ore. A string of recent discoveries ab...renewed interest in this multi-purpose nutrient, i...ho are deficient in it, spurred research and even ...ic." , On issues ranging from the health of your...even vulnerability to influenza, vitamin D is now ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 1Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 2Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 3Photos 3A FDA Approves 12 Month Labeling Update for EVOLENCE 28R 29 Collagen Based Facial Filler 12508 4Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 1Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17 2009 48147 2
...covery that sheds new light upon the growth and de...rful but somewhat mysterious components of the bod...se against cancer and infectious diseases. , Scien...are generated in bone marrow, but Michael Caligiur... and the senior author of the study, says research...
...ntific world has accepted for more than 100 years,...eir grandparents, bypassing genetic abnormalities ...nts apparently have hidden templates containing ge...at can be transferred to their offspring, even tho...rding to Purdue University researchers. This disco...
... severe malaria before they reach hospital, has th... this week,s BMJ. , Every year over a million chi...talities occur outside hospital, especially in rur...lf of deaths occur within 24 hours of admission. ,...t possible to administer outside hospital, so buyi...
Other Biology News:Scientists identify new model Of NK cell development 2Scientists identify new model Of NK cell development 3Plants defy Mendel's inheritance laws, may prompt textbook changes 2Plants defy Mendel's inheritance laws, may prompt textbook changes 3
Yeast-GFP 96-well Plates from Invitrogen
...joined forces with the Mickle Laboratory Engineeri...hopper. This tissue sectioning system has been des...experiments and to be especially applicable to sma...from small organs. Its special features cause much...
Earle's Balanced Salt Solution, 10x (EBSS) from Sigma-Aldrich
...ive peptides are molecules of peptidic nature or o...vity which can be developed at the industrial leve...o-food applications. In this way it is possible to... for therapeutic applications. Primm offers a desi...
Biology Products: